“We want to consider Medicare coverage of new treatments very carefully in light of the evidence available. Our process will include opportunities to hear from many stakeholders, including patient advocacy groups, medical experts, states, issuers, industry professionals, and family members and caregivers of those living with this disease” CMS( Centers for Medicare and Medicaid Services) Administrator Chiquita Brooks-LaSure said in a statement
Category:
Facts
Latest
Remdesivir, Hydroxychloroquine show no antiviral effect against Covid-19: Study
‘Sputnik, AstraZeneca mix & match results by end of July’
This approach has been really pioneered by Sputnik V in the beginning. So we are open for mix and match a Covishield in India. We believe there will be a great result. Covishield is the same vaccine as AstraZeneca so we believe that trials will show high efficacy. We hope that the Serum Institute of India (SII) can produce Sputnik V and mix and match as well. It will be a true partnership,” said Dmitriev.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.